Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jason Haas currently holds 62,908 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Haas has been a net buyer of LGND stock. They have purchased $181.5K and sold $0 worth of shares.
Jason Haas's most recent insider trade was on May 8, 2026, when they purchased 1,000 shares at $20.00 per share.
Jason Haas serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 18 insider transactions totaling $181.5K over their tenure at the company.
Jason Haas holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Jason Haas has shown a buying trading pattern, with $181.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jason Haas was on Sep 12, 2024, when they purchased $76.2K worth of SYRS shares. This transaction involved 45,344 shares at $1.68 per share.
Jason Haas currently owns 62,908 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jason Haas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jason Haas has 18 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for Jason Haas and 40,000+ other insiders.